Personal Genome Diagnostics
Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System
Under the deal, DUHS will establish PGDx's next-generation sequencing-based Elio Tissue Complete platform for the genomic profiling of cancer in its lab.
Personal Genome Diagnostics to Build Commercial Infrastructure, Drive Partnerships With New Funding
Premium
The firm expects to release an expanded liquid biopsy panel this year to help pharmaceutical partners perform blood-based biomarker discovery work.Â
Qiagen Launches 'Digital Partner' Program to Expand Bioinformatics Reach
Initial partners in the program include Thermo Fisher Scientific, GNS Healthcare, DNAnexus, Personal Genome Diagnostics, and the Wellcome Sanger Institute.
Personal Genome Diagnostics Raises $103M in Series C Financing
The firm will use the proceeds to expand its tissue and liquid biopsy product portfolio, as well as to fund future pharma and biotechnology partnerships.
PGDx, Qiagen Partner on Clinical Decision Support for Molecular Cancer Testing
Laboratories that purchase PGDx Elio genomic profiling tests will receive access to Qiagen's QCI Interpret One for rapid, evidence-based variant interpretation.